These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Communication of gene technology--a difficult enterprise: a journalist's view on biotech communication. Spahl T; Deichmann T Biotechnol J; 2007 Sep; 2(9):1064-6. PubMed ID: 17768770 [No Abstract] [Full Text] [Related]
43. [Science and education and for the clinic and practice]. Sterry W J Dtsch Dermatol Ges; 2008 Aug; 6(8):617. PubMed ID: 18801143 [No Abstract] [Full Text] [Related]
45. A reappraisal of biomaterials science. Williams D Med Device Technol; 2009 Oct; 20(6):8-9. PubMed ID: 20302135 [TBL] [Abstract][Full Text] [Related]
46. From regenerative medicine to human design: what are we really afraid of? Stock G Free Inq; 2004; 24(4):27-30. PubMed ID: 15835004 [No Abstract] [Full Text] [Related]
47. Integrated farming: why organic farmers should use transgenic crops. Ammann K N Biotechnol; 2008; 25(2-3):101-7. PubMed ID: 18824150 [TBL] [Abstract][Full Text] [Related]
49. The state of nanoparticle-based nanoscience and biotechnology: progress, promises, and challenges. Pelaz B; Jaber S; de Aberasturi DJ; Wulf V; Aida T; de la Fuente JM; Feldmann J; Gaub HE; Josephson L; Kagan CR; Kotov NA; Liz-Marzán LM; Mattoussi H; Mulvaney P; Murray CB; Rogach AL; Weiss PS; Willner I; Parak WJ ACS Nano; 2012 Oct; 6(10):8468-83. PubMed ID: 23016700 [TBL] [Abstract][Full Text] [Related]
50. Genetic engineering and biotechnology, the future of making drugs? Folkers G Pharm Acta Helv; 1994 Jul; 69(1):1. PubMed ID: 7938071 [No Abstract] [Full Text] [Related]
51. Clone on the range: What animal biotech is bringing to the table. Dove AW Nat Biotechnol; 2005 Mar; 23(3):283-5. PubMed ID: 15765075 [No Abstract] [Full Text] [Related]
52. Plant transgenic science knowledge. Vain P Nat Biotechnol; 2005 Nov; 23(11):1348-9. PubMed ID: 16273057 [No Abstract] [Full Text] [Related]
53. GM giants pair up to do battle. Mitchell P Nat Biotechnol; 2007 Jul; 25(7):695-6. PubMed ID: 17621277 [No Abstract] [Full Text] [Related]
54. Beyond silencing--engineering applications of RNA interference and antisense technology for altering cellular phenotype. Hebert CG; Valdes JJ; Bentley WE Curr Opin Biotechnol; 2008 Oct; 19(5):500-5. PubMed ID: 18760358 [TBL] [Abstract][Full Text] [Related]
55. Science in Japan: creating new structures. Science; 1994 Nov; 266(5188):1169-90. PubMed ID: 7973696 [No Abstract] [Full Text] [Related]
56. Our synthetic future. de S Cameron NM; Caplan A Nat Biotechnol; 2009 Dec; 27(12):1103-5. PubMed ID: 20010585 [No Abstract] [Full Text] [Related]
57. Gene therapy: cursed or inching towards credibility? Branca MA Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060 [No Abstract] [Full Text] [Related]
58. The future of gene therapy in the UK. Seymour LW Trends Biotechnol; 2006 Aug; 24(8):347-9. PubMed ID: 16782218 [TBL] [Abstract][Full Text] [Related]